Skip to main content
MJHS
Navigation
Journal Navigation
Article Navigation
Surgical treatment of dysphagia lusoria caused by an aberrant right subclavian artery: a case report and literature review
Dumitru Casian1,2, Igor Maxim1,3, Serghei Gutu3, Alexandru Predenciuc1,2*, Sergiu Danu2, Ion Burlacu1,3
https://doi.org/10.52645/MJHS.2026.1.19
Dysphagia lusoria refers to dysphagia caused by an aberrant right subclavian artery (ARSA), a rare congenital anomaly of the aortic arch. This article presents a clinical case of symptomatic ARSA, accompanied by a comprehensive review of its anatomical, clinical, and therapeutic aspects.
Correlation between pathogenetic factors and vascular endothelial damage in patients with rheumatoid arthritis
Eugeniu Russu1,2, Liliana Groppa1, Lia Chișlari1, Svetlana Agachi1, Marius Semionov1, Chiril Nartea1, Iosif Leanca1, Artemie Pastuhov1
https://doi.org/10.52645/MJHS.2026.1.16
Systemic rheumatoid vasculitis accounts for 1 to 5% of complications seen in rheumatoid arthritis, while autopsy studies report an average of 23% incidence. This enormous difference in numbers emphasizes the rate of misdiagnosis or underdiagnosis of systemic rheumatoid vasculitis. It mainly affects people with a median age of 65 years. It is particularly noteworthy, as systemic rheumatoid vasculitis has a high mortality and relapse rate. Also, the multifactorial aetiology: cytokines/immune cells and other particles determines clinical complexity of this type of angiitis
Advances in disease-modifying therapies for multiple sclerosis: global updates and a regional comparison between the Republic of Moldova and Romania
Anna Belenciuc1,2*, Olesea Odainic2, Marina Sangheli1, Elena Manole1, Carmen Adella Sîrbu3,4,5, Vitalie Lisnic1
https://doi.org/10.52645/MJHS.2026.1.15
The therapeutic landscape of multiple sclerosis has undergone a remarkable transformation over the past two decades. The paradigm has shifted from reliance on moderate-efficacy, first-generation injectable therapies toward earlier adoption of high-efficacy disease-modifying treatments, particularly in relapsing forms of MS. This evolution reflects an increasing focus on early intensive treatment strategies aimed at preserving long-term neurological function and brain health.
Pregnancy-related inflammatory markers and their association with perinatal mental illness: a systematic review
Larisa Boronin*, Jana Chihai, Igor Nastas
https://doi.org/10.52645/MJHS.2026.1.14
This study investigates the relationship between immune dysregulation and perinatal mental disorders by analyzing clinical data and biomarker profiles in pregnant individuals with varying severity of psychiatric symptoms. Understanding these associations may support the development of early screening tools and targeted interventions to improve maternal and infant mental health outcomes.
Thromboprophylaxis in pregnancy, delivery and puerperium: a review of literature and current guidelines
Corina Cardaniuc*, Irina Sagaidac
https://doi.org/10.52645/MJHS.2026.1.13
Venous thromboembolism is one of the leading causes of maternal morbidity and mortality. Pregnancy induces a hypercoagulable state as an adaptive mechanism to prevent hemorrhage during childbirth. These physiological changes significantly increase the risk of venous thromboembolism – by up to six-fold during pregnancy and up to 10-fold during the postpartum period compared to the non-pregnant population. Given these risks, proper identification of patients who may benefit from thromboprophylaxis is essential to improve maternal outcomes.
Micronutrient needs and supplementation strategies during pregnancy
Maria Cemortan*, Irina Sagaidac, Olga Cernetchi
https://doi.org/10.52645/MJHS.2026.1.12
Micronutrient deficiencies during pregnancy remain a major global public health concern, with implications for maternal health, fetal development, and long-term child outcomes. International organizations such as the WHO and FIGO have issued evidence-based guidelines on micronutrient supplementation, which are increasingly being adapted into national protocols.
The iCREATE registry: a model for strengthening injury surveillance in the Republic of Moldova
Angela Cazacu-Stratu1*, Svetlana Cociu1, Patricia Maria Marga2, Dumitru Cartaleanu1, Diana Dulf2, Serghei Cebanu1
https://doi.org/10.52645/MJHS.2026.1.11
Injuries represent a major public health issue, causing approximately 16,000 deaths globally each day (10% of all deaths), which is 32% more than the combined total caused by malaria, tuberculosis, and HIV/AIDS. Over the past 15 years, the WHO and regional initiatives have supported the piloting of trauma registries in low- and middle-income countries as essential tools for monitoring, planning, and prevention.
Developing and validating a questionnaire on knowledge and attitudes in health research ethics
Adriana Paladi1, Valentin Mîța2, Lilian Șaptefrați3
https://doi.org/10.52645/MJHS.2026.1.10
Research ethics and integrity are fundamental for safeguarding human participants and ensuring trustworthy scientific practices. Understanding researchers’ knowledge, attitudes, and perceptions regarding ethical standards is important for all health researchers, but particularly relevant for early-career researchers. While several international instruments exist to evaluate specific aspects of research ethics, such as plagiarism, organizational climate, or responsible conduct of research, a multidimensional and contextually relevant tool is required.